Biologic Name Standardization
Biologic Name Standardization is a methodological framework within regulatory bioinformatics that establishes consistent, unique, and globally recognized nomenclature for biologic products to ensure unambiguous identification, safety, and traceability across development, manufacturing, and clinical use.
2
Publications
2.1K
Citations
13
Authors
17
Institutions
Publications per year
2017–2026
0
Variants
Biologic Nomenclature Standardization
Parents
2
Similar Names for Similar Biologics
Nicole Casadevall, Thomas Felix, Bruce Strober et al. · BioDrugs · 2014 · 14 citations
1–2 of 2
13
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 13
17
The University of Texas MD Anderson Cancer Center
Houston, United States
1 h-index
1 publications
2K citations

Sorbonne Université
Paris, France
1 h-index
1 publications
14 citations
Yale University
New Haven, United States
1 h-index
1 publications
2K citations

Karolinska Institutet
Stockholm, Sweden
1 h-index
1 publications
2K citations

St. Jude Children's Research Hospital
Memphis, United States
1 h-index
1 publications
2K citations
Hôpital Saint-Antoine
Paris, France
1 h-index
1 publications
14 citations

University of Alabama at Birmingham
Birmingham, United States
1 h-index
1 publications
14 citations
Athersys (United States)
Cleveland, United States
1 h-index
1 publications
2K citations
1–8 of 17
1 publications · 14 citations
1
h-index
1 publications · 2K citations
1
h-index
1–2